4//SEC Filing
Ros Matthew 4
Accession 0000899243-22-032672
CIK 0001622229other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:35 PM ET
Size
5.8 KB
Accession
0000899243-22-032672
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-10-03$9.08/sh+1,419$12,879→ 1,419 totalExercise: $14.33From: 2022-10-03Exp: 2032-10-03→ Common Stock (1,419 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
Documents
Issuer
Cogent Biosciences, Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001673802
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:35 PM ET
- Size
- 5.8 KB